Skip to content
ICEDOC

South and East Mediterranean College of Oncology

SEMCO

A non-governmental, non-profit initiative for professional and public education in all fields of cancer, and for building research capacity, across the South and East Mediterranean.

SEMCO is affiliated to the Egyptian Foundation for Cancer Research (EFCR) and was founded in collaboration with ICEDOC. Behind it is the experience of ICEDOC’s Experts in Cancer Without Borders in many parts of the world.

We believe that regional scientific and medical activity should rise from the region itself. The role of SEMCO’s executives is to serve colleagues in the region and to build collaboration with regional and international organizations and societies. SEMCO adopts ICEDOC’s three Cs: cooperation, collaboration and coordination with all local, regional and international organizations and cancer societies. Its role is not to compete, but to cooperate.

Why SEMCO?

The South and East Mediterranean extends from Turkey to Morocco and Mauritania. It sits at the meeting point of many regions and has mixed characteristics that show in cancer control and training too. It is Europe’s southern and eastern neighbor, and also part of Africa and, through Turkey, of Asia.

National incomes range from small, high-income populations such as the Emirates and Qatar to larger lower-middle-income countries such as Egypt and upper-middle-income countries such as Lebanon. Cancer management facilities, training and research opportunities, and even the profile of early and advanced cases do not necessarily follow income. Cancer of the cervix is not among the most common cancers in Egypt, while stage III and IV cervical cancer is a common problem in Saudi Arabia and the Gulf. Breast cancer is the most common cancer among women across the whole region. Hepatocellular carcinoma following hepatitis C is a national cancer problem in Egypt, which calls for more professional and public education, prevention and early detection.

Most cancer care providers were trained on Euro-American curricula, at home or in neighboring countries, and some in Western Europe or the USA. Medical education is mostly in English or French, with some in Arabic or mixed English and Turkish. English is understood by most physicians, but French, Arabic and Turkish must be taken into account in training, particularly for nursing.

Many consultants and university staff already belong to international bodies and attend their conferences. Yet there is a lack of local, regional and international coordination; a lack of training in multidisciplinary, balanced approaches suited to real regional conditions; and a lack of capacity for relevant research and clinical trials, although the region could be a considerable contributor to cancer research.

Board

Honorary President
Prof. Dr. Sherif Omar
Co-Presidents
Prof. Dr. Hussein Khaled and Prof. Dr. Ahmed Elzawawy
General Director
Prof. Dr. Ahmed Elzawawy
Manager
Dr. Atef Badran
Director, SEMCO Turkey
Prof. Munir Kinay
Director, SEMCO Gulf Region
Dr. Aly Abdel Razek

Senior scientific leaders, advisers and contributors are experts in cancer management in the South and East Mediterranean region.

Conferences

  • 5–6 Apr 2007

    First SEMCO-ASCO Conference: MCMC

    National Training Centre, Cairo, Egypt

  • 5–7 Dec 2007

    SEMCO-ESMO-ACOD Conference

    Palestine Hotel, Alexandria, Egypt

  • 26–28 Mar 2008

    Second SEMCO-ASCO Conference: Advanced Course

    Ain Shams Training Centre, Cairo, Egypt

  • 20–22 Nov 2008

    Third SEMCO-ASCO Conference: MCMC

    Çeşme, Izmir, Turkey

  • 17–19 Mar 2009

    Second Annual African Breast Cancer Conference

    Hilton Hotel, Cairo, Egypt

  • 15–17 Apr 2009

    Fourth SEMCO-ASCO Conference: EPEC-O

    Hilton Hotel, Cairo, Egypt

  • 25–26 Feb 2010

    Fifth SEMCO-ASCO Conference: MCMC

    Abu Dhabi, UAE

  • 27–28 Jan 2011

    Sixth SEMCO-ASCO Conference: ICTW

    Ramses Hilton Hotel, Cairo, Egypt

Since April 2020, because of the COVID-19 pandemic, most lectures and courses have moved to online webinars.